Skip to main content

Refine your results

Filters
Search
Include spaces in matter number if applicable. Ex.: 182 3125
Date
Displaying 14521 - 14540 of 45408
Early Termination Notices

20140259: Kentz Corporation Limited; Valerus Compression Services, L.P.

… Limited; Valerus Compression Services, L.P. HSR Early Termination Notice 20140259: Kentz Corporation Limited; Valerus … Services, L.P. 20140259 Newco LLC Valerus Mexico Holding VIP de Mexico S de RL de CV Valerus Services C.C.A. …
Date
Acquiring Party
Kentz Corporation Limited
Acquired Party
Valerus Compression Services, L.P.
Acquired Entities
Newco LLC
Valerus Mexico Holding VIP de Mexico S de RL de CV
Valerus Services C.C.A.
Valerus Eastern Hemisphere FZE
Valerus Compression Services de Energia Ltda.
Early Termination Notices

20140235: TCV VII, L.P.; Spotify Technology S.A.

… 20140235: TCV VII, L.P.; Spotify Technology S.A. HSR Early Termination Notice 20140235: TCV VII, L.P.; Spotify Technology S.A. 20140235 Spotify Technology S.A. Spotify Technology …
Date
Acquiring Party
TCV VII, L.P.
Acquired Party
Spotify Technology S.A.
Acquired Entities
Spotify Technology S.A.
HSR Informal Interpretations

1312004 Informal Interpretation

… 1312004 Informal Interpretation 1312004 Informal Interpretation From … Regarding the Effective Date of New Rule 801.2 Mike and Kate I hope the snow has not been treating you too … Can you please confirm that the old rule is effective for transactions signed, but not closed, on or prior to 11:59 pm …
Date
Rule
801.1
The key is date of closing.
Cases and Proceedings

Actavis, Inc. and Warner Chilcott PLC, In the Matter of

… Actavis, Inc. and Warner Chilcott PLC, In the Matter of Actavis, Inc. and Warner Chilcott PLC, In the Matter of Under a …

Under a settlement, the FTC required Watson Pharmaceuticals, Inc. and Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz International GmbH and Par Pharmaceuticals, Inc, and relinquish the manufacturing and marketing rights to three others, to settle charges that Watson’s proposed $5.9 billion acquisition of Actavis would otherwise be anticompetitive.The settlement protects competition in the markets for 21 current and future generic drugs, used to treat a wide range of conditions ranging from hypertension and diabetes to anxiety and attention deficit hyperactivity disorder (ADHD).

Type of Action
Administrative
Last Updated
FTC Matter/File Number
131 0152
Docket Number
C-4414
Displaying 14521 - 14540 of 45408
Return to top